AAAAAA

   
Results: 1-15 |
Results: 15
Untangling the ErbB signalling network
Authors: Yarden, Y Sliwkowski, MX
Citation: Y. Yarden et Mx. Sliwkowski, Untangling the ErbB signalling network, NAT REV MOL, 2(2), 2001, pp. 127-137
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey
Authors: Koeppen, HKW Wright, BD Burt, AD Quirke, P McNicol, AM Dybdal, NO Sliwkowski, MX Hillan, KJ
Citation: Hkw. Koeppen et al., Overexpression of HER2/neu in solid tumours: an immunohistochemical survey, HISTOPATHOL, 38(2), 2001, pp. 96-104
Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
Authors: Mann, M Sheng, HM Shao, JY Williams, CS Pisacane, PI Sliwkowski, MX DuBois, RN
Citation: M. Mann et al., Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth, GASTROENTY, 120(7), 2001, pp. 1713-1719
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4
Authors: Lee, H Akita, RW Sliwkowski, MX Maihle, NJ
Citation: H. Lee et al., A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4, CANCER RES, 61(11), 2001, pp. 4467-4473
Effects of in vivo heregulin beta i treatment in wild-type and ErbB gene-targeted mice depend on receptor levels and pregnancy
Authors: O'Shea, S Johnson, K Clark, R Sliwkowski, MX Erickson, SL
Citation: S. O'Shea et al., Effects of in vivo heregulin beta i treatment in wild-type and ErbB gene-targeted mice depend on receptor levels and pregnancy, AM J PATH, 158(5), 2001, pp. 1871-1880
Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro
Authors: Patel, NV Acarregui, MJ Snyder, JM Klein, JM Sliwkowski, MX Kern, JA
Citation: Nv. Patel et al., Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro, AM J RESP C, 22(4), 2000, pp. 432-440
Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1 (vol 6, pg 537, 1999)
Authors: Kern, JA Akita, RW Sliwkowski, MX
Citation: Ja. Kern et al., Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1 (vol 6, pg 537, 1999), CANC GENE T, 7(2), 2000, pp. 166-166
CD20: A gene in search of a function
Authors: Riley, LK Sliwkowski, MX
Citation: Lk. Riley et Mx. Sliwkowski, CD20: A gene in search of a function, SEMIN ONCOL, 27(6), 2000, pp. 17-24
A potential role for activated HER-2 in prostate cancer
Authors: Agus, DB Akita, RW Fox, WD Lofgren, JA Higgins, B Maiese, K Scher, HI Sliwkowski, MX
Citation: Db. Agus et al., A potential role for activated HER-2 in prostate cancer, SEMIN ONCOL, 27(6), 2000, pp. 76-83
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-ovorexpresessed tamoxifen-resistant breast cancer cells
Authors: Kurokawa, H Lenferink, AEG Simpson, JF Pisacane, PI Sliwkowski, MX Forbes, JT Arteaga, CL
Citation: H. Kurokawa et al., Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-ovorexpresessed tamoxifen-resistant breast cancer cells, CANCER RES, 60(20), 2000, pp. 5887-5894
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells
Authors: Aguilar, Z Akita, RW Finn, RS Ramos, BL Pegram, MD Kabbinavar, FF Pietras, RJ Pisacane, P Sliwkowski, MX Slamon, DJ
Citation: Z. Aguilar et al., Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells, ONCOGENE, 18(44), 1999, pp. 6050-6062
Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1
Authors: Kern, JA Wakita, R Sliwkowski, MX
Citation: Ja. Kern et al., Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1, CANC GENE T, 6(6), 1999, pp. 537-545
Nonclinical studies addressing the mechanism of action of trastuzumab (herceptin)
Authors: Sliwkowski, MX Lofgren, JA Lewis, GD Hotaling, TE Fendly, BM Fox, JA
Citation: Mx. Sliwkowski et al., Nonclinical studies addressing the mechanism of action of trastuzumab (herceptin), SEMIN ONCOL, 26(4), 1999, pp. 60-70
A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2
Authors: Schaefer, G Akita, RW Sliwkowski, MX
Citation: G. Schaefer et al., A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2, J BIOL CHEM, 274(2), 1999, pp. 859-866
Binding specificities and affinities of egf domains for ErbB receptors
Authors: Jones, JT Akita, RW Sliwkowski, MX
Citation: Jt. Jones et al., Binding specificities and affinities of egf domains for ErbB receptors, FEBS LETTER, 447(2-3), 1999, pp. 227-231
Risultati: 1-15 |